News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Week In Review: Week's China Pharma Deals Top $1 Billion



9/5/2017 1:55:05 PM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Deals and Financings

- Berry Genomics, a Beijing diagnostics/sequencing company, completed a $648 million reverse merger on the Shenzhen exchange;

- China's iPharma agreed in principle to a $120 million deal for Greater China rights to a clinical-stage immunotherapy candidate from Mologen of Berlin;

- Suzhou's CF PharmaTech raised $65 million in a Series D funding to advance its inhalation products;

- aTyr Pharma, a public San Diego-Hong Kong biotherapeutics company, announced a $45.8 million private placement;

- Akeso Biopharma of Zhongshan closed a $45 million B round, led by the GTJA Investment Group, to develop its antibody portfolio;

- Fosun Pharma paid $40 million to acquire a 65% stake in Shanghai SinoMedCare Biotech, a medical marketing company focused on tier 3 China cities;

- Distinct Healthcare of China closed a $40 million C funding round to support its chain of China medical clinics;

- Shuidi, a China crowdfunding platform aimed at helping people pay for healthcare, raised $24 million in a Series A round led by Tencent Holdings;

Company News

- Beijing's Yisheng Biopharma said its first-in-class immuno-oncology candidate, YS-ON-001, showed "breakthrough" anti-tumor efficacy in pre-clinical tests;

Trials and Approvals

- iCAD, a New Hampshire medical device maker, announced CFDA approval of its balloon applicators, which are used in Brachytherapy treatment of breast cancer.

Read at ChinaBio Today


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES